Back to search
FDAFDA · Food and drugs·Recall number Z-2057-2017

MEDHOT MTI 2000 THERMAL IMAGING SYSTEM - TotalVision software with Elevated Body Temperature Screening module, for use as a medical diagnostic purposes as part of a telethermographic system utilizing FLIR cameras, Models A615sc and A315sc. Cameras are private labeled as MAX Basic, MAX 76 and MAX 307.

Published May 17, 2017 · Recall initiated: January 14, 2017

Summary

FDA records medical device Class II recall Z-2057-2017, published May 17, 2017 and initiated January 14, 2017. Recalling firm: Med-Hot Thermal Imaging, Inc.; Status: Terminated; Reported quantity: 12; Lot: P/N 18001-EBT-MP-D with FLIR A315 camera P/N 15102-EBT-MP-D wjth FLIR A615 camera TotalVision Software versions 1.6  1.7.1. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Indications for use are not cleared or approved for market in the U.S.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Med-Hot Thermal Imaging, Inc.
Distributor
US: AL and NJ - Foreign: Nigeria
Lot
P/N 18001-EBT-MP-D with FLIR A315 camera P/N 15102-EBT-MP-D wjth FLIR A615 camera TotalVision Software versions 1.6  1.7.1
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was MEDHOT MTI 2000 THERMAL IMAGING SYSTEM - TotalVision software with Elevated Body Temperature Screening module, for use as a medical diagnostic purposes as part of a telethermographic system utilizing FLIR cameras, Models A615sc and A315sc. Cameras are private labeled as MAX Basic, MAX 76 and MAX 307. recalled?

Yes. FDA published recall Z-2057-2017 on May 17, 2017. Reported hazard: Indications for use are not cleared or approved for market in the U.S.

What should I do if I have this product?

Voluntary: Firm initiated · Letter